Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Rivka Ayalon"'
Autor:
Arezou Khosroshahi, Rivka Ayalon, Laurence H. Beck, David J. Salant, Donald B. Bloch, John H. Stone
Publikováno v:
International Journal of Rheumatology, Vol 2012 (2012)
Patients with IgG4-related disease (IgG4-RD) share histopathological characteristics that are similar across affected organs. The finding of infiltration with IgG4+ plasma cells in the proper clinical and histopathological contexts connects a large n
Externí odkaz:
https://doaj.org/article/c69eb8066537446ea5c148af1671a159
Publikováno v:
Pediatric Nephrology ISBN: 9783642278433
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d354206f6b3d67f789719a369c56e89
https://doi.org/10.1007/978-3-030-52719-8_94
https://doi.org/10.1007/978-3-030-52719-8_94
Publikováno v:
Pediatric Nephrology. 36:19-30
Membranous nephropathy (MN) is an immune complex-mediated cause of the nephrotic syndrome that can occur in all age groups, from infants to the very elderly. However, nephrotic syndrome in children is more frequently caused by conditions such as mini
Autor:
David J. Salant, Rivka Ayalon, Laith Al-Rabadi, Laurence H. Beck, Joel Henderson, Jennifer E. Ballard, Ramon G. Bonegio, Alan M. Fujii
Publikováno v:
American Journal of Kidney Diseases. 67:775-778
There is little information about pregnancy outcomes in patients with active membranous nephropathy (MN), especially those with circulating autoantibodies to M-type phospholipase A₂receptor (PLA₂R), the major autoantigen in primary MN. We present
Autor:
Laurence H. Beck, Salima Sadruddin, Rivka Ayalon, Dhiren Kumar, H. Davis Massey, Anne L. King, Hasan Fattah, Gaurav Gupta, Pamela Kimball, Jason M. Kidd, Luis F. Quintana, Todd W.B. Gehr
Publikováno v:
Clinical Transplantation. 30:461-469
Previous studies that have assessed the association of pre-transplant antiphospholipase A2 receptor autoantibody (PLA2R-Ab) concentration with a recurrence of membranous nephropathy (rMN) post-kidney transplant have yielded variable results. We teste
Autor:
Laurence H. Beck, Fernando G. Cosio, Dana G. Sandor, Andrea G. Kattah, M. J. Gandhi, Elizabeth C. Lorenz, Sanjeev Sethi, Rivka Ayalon, Fernando C. Fervenza, David J. Salant
Publikováno v:
American Journal of Transplantation. 15:1349-1359
About 70% of patients with primary membranous nephropathy (MN) have circulating anti-phospholipase A2 receptor (PLA2R) antibodies that correlate with disease activity, but their predictive value in post-transplant (Tx) recurrent MN is uncertain. We e
Autor:
Wolfgang Schlumberger, Petra Heerings-Rewinkel, Laurence H. Beck, Rivka Ayalon, Jan Willem Cohen Tervaert, David J. Salant, Jan Damoiseaux, Pieter van Paassen, Sjoerd A.M.E.G. Timmermans
Publikováno v:
American Journal of Clinical Pathology. 142:29-34
Objectives: Autoantibodies against the M-type phospholipase A2 receptor 1 (anti-PLA2R1) have been demonstrated to be very specific for idiopathic membranous nephropathy (MN). We studied a novel enzyme-linked immunosorbent assay (ELISA) and compared r
Autor:
Laurence H. Beck, Rivka Ayalon
Publikováno v:
Pediatric Nephrology. 30:31-39
Membranous nephropathy (MN) is an immune complex-mediated cause of the nephrotic syndrome that can occur in all age groups, from infants to the elderly. While systemic disorders such as hepatitis B infection or lupus may more frequently cause seconda
Autor:
Edward Y. Skolnik, Sheena Surindran, Nazia Hasan, Rivka Ayalon, David J. Salant, Laura Barisoni, Laurence H. Beck, Lada Beara-Lasic
Publikováno v:
Clinical Kidney Journal
Antibodies to myeloperoxidase (MPO) and proteinase 3 (PR3) have been demonstrated to mediate anti-neutrophil cytoplasmic antibody (ANCA)-associated disease. For membranous nephropathy, antibodies to the podocyte-expressed phospholipase A2 receptor (a
Treatment of Resistant Glomerular Diseases with Adrenocorticotropic Hormone Gel: A Prospective Trial
Autor:
Gerald B. Appel, Rivka Ayalon, Laurence H. Beck, Jai Radhakrishnan, Pietro A. Canetta, Andrew S. Bomback
Publikováno v:
American Journal of Nephrology. 36:58-67
Background: Adrenocorticotropic hormone (ACTH) has shown promising results in glomerular diseases resistant to conventional therapies, but the reported data have solely been from retrospective, observational studies. Methods: In this prospective, ope